IMM 6.90% 31.0¢ immutep limited

Ann: Efti to be evaluated in new triple combination therapy trial, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 11,294 Posts.
    lightbulb Created with Sketch. 733
    All guns blazing therapy. Must have a lot of confidence in the side effect profile. So is that Efti with Pembo (anti PD-1) and ??? Paclitaxel???. IMM is familiar with all of these?


    Paclitaxel has been used with efti in AIPAC, and EOS in China.

    Is this a treatment to piggyback off the success of the following treatments, but in solid tumours?:
    https://www.fda.gov/drugs/resources...therapy-first-line-treatment-metastatic-nsclc
    https://www.fda.gov/drugs/resources...ves-pembrolizumab-esophageal-or-gej-carcinoma

    If the efti triple combo can get better results than the above two trials, they will be able to do another crap raise at a far higher SP - lol

    Does anybody know of any solid tumour trials that are more comparable than the above two?
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.020(6.90%)
Mkt cap ! $450.9M
Open High Low Value Volume
29.0¢ 31.5¢ 29.0¢ $1.805M 5.903M

Buyers (Bids)

No. Vol. Price($)
4 193400 30.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 1000 1
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.